OMCL vs. FIT, MDRX, HSTM, HMI, CRTX, ZEPP, OSS, SCKT, CERN, and AAPL
Should you be buying Omnicell stock or one of its competitors? The main competitors of Omnicell include Fitbit (FIT), Veradigm (MDRX), HealthStream (HSTM), Huami (HMI), Cortexyme (CRTX), Zepp Health (ZEPP), One Stop Systems (OSS), Socket Mobile (SCKT), Cerner (CERN), and Apple (AAPL).
Omnicell (NASDAQ:OMCL) and Fitbit (NYSE:FIT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, risk, valuation, profitability and dividends.
Fitbit received 298 more outperform votes than Omnicell when rated by MarketBeat users. However, 67.82% of users gave Omnicell an outperform vote while only 66.75% of users gave Fitbit an outperform vote.
In the previous week, Omnicell had 2 more articles in the media than Fitbit. MarketBeat recorded 2 mentions for Omnicell and 0 mentions for Fitbit. Omnicell's average media sentiment score of 1.58 beat Fitbit's score of 0.00 indicating that Omnicell is being referred to more favorably in the media.
Omnicell currently has a consensus price target of $42.20, indicating a potential upside of 45.92%. Given Omnicell's higher probable upside, research analysts clearly believe Omnicell is more favorable than Fitbit.
97.7% of Omnicell shares are held by institutional investors. 2.6% of Omnicell shares are held by insiders. Comparatively, 18.6% of Fitbit shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Fitbit has a net margin of 0.00% compared to Omnicell's net margin of -1.91%. Omnicell's return on equity of 2.41% beat Fitbit's return on equity.
Omnicell has higher earnings, but lower revenue than Fitbit. Omnicell is trading at a lower price-to-earnings ratio than Fitbit, indicating that it is currently the more affordable of the two stocks.
Summary
Omnicell beats Fitbit on 10 of the 16 factors compared between the two stocks.
Get Omnicell News Delivered to You Automatically
Sign up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OMCL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Omnicell Competitors List
Related Companies and Tools
